Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Effects of Addition to Infant Formula of 2-fucosyllactose (2-FL) on Growth, Fecal Bacterial Populations and Safety

NCT03109223 is registered in ClinicalTrials.gov with PBM Nutritionals as lead sponsor.

NCT NCT03109223
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03109223 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Effects of Addition to Infant Formula of 2-fucosyllactose (2-FL) on Growth, Fecal Bacterial Populations and Safety
Lead sponsor
PBM Nutritionals
Phase
Not applicable
Overall status
Completed
Start date
July 15, 2017
Completion date
May 17, 2021
Enrollment
221 (actual)
Sites
6

Conditions

As the registry lists them; a condition with its own page is linked.

growth of infants